[High risk pathophysiology and the molecular mechanism of arteriosclerosis].
Yamada
Nobuhiro
N
D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / Q000502:physiology; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000209:etiology; D004734:Energy Metabolism / Q000235:genetics; D005786:Gene Expression Regulation; D006801:Humans; D055504:Insulin Receptor Substrate Proteins; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics; D008019:Life Style; D024821:Metabolic Syndrome / Q000209:etiology / Q000503:physiopathology; D010750:Phosphoproteins / Q000235:genetics; D012306:Risk; D051780:Sterol Regulatory Element Binding Protein 1 / Q000502:physiology; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D014157:Transcription Factors / Q000502:physiology
D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; C526297:IRS2 protein, human; D055504:Insulin Receptor Substrate Proteins; D047908:Intracellular Signaling Peptides and Proteins; D010750:Phosphoproteins; D051780:Sterol Regulatory Element Binding Protein 1; C069203:TFE3 protein, human; D014157:Transcription Factors